Scientific innovation is accelerating. But commercialization? It’s stuck in the past — fragmented, reactive and increasingly unsustainable. Learn why the AI Agency is the catalyst life sciences commercialization has been waiting for in this POV.
Faruk Capan, Chief Innovation Officer at EVERSANA, lays out a bold new vision for life sciences leaders: a future powered by agentic AI. Intelligent systems that don’t just support decisions, but act on them.
What You’ll Learn:
- Why more than half of drug launches fail
- How agentic AI transforms commercialization from slow and siloed to fast, adaptive and integrated
- What EVERSANA and Google are building together to redefine life sciences marketing
- How senior leaders can harness AI to drive speed, precision and scale across the product lifecycle
If you’re a senior leader, commercialization strategist or digital transformation leader, this is a strategic imperative. The AI agency model isn’t a future concept. It’s already reshaping how brands engage, launch and grow.
As the architect behind the EVERSANA AI Accelerator™, Faruk Capan is leading the charge to replace outdated workflows with intelligent, scalable systems, and he’s inviting you to lead alongside him in this POV.
Download the POV to Discover:
- The economic impact of agentic AI
- Real-world applications across medical, legal, regulatory and market access
- How to future-proof your organization with AI-native infrastructure
Fill out the form to access the full POV and learn how to reimagine your company’s model to stay ahead.
Author
Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,500 employees globally that joined EVERSANA in December 2021. Faruk…